Ralliant

Ralliant Corporation Faces Securities Fraud Investigation

Citigroup

Citigroup maintains Buy rating, lowers price target to $51 for Ralliant.

Ralliant: RBC Capital Downgrades to Sector Perform, PT to $41 from $52.

Ralliant: Oppenheimer Downgrades PT to $50 from $60, Maintains Outperform Rating

Truist Securities Downgrades Ralliant to Buy with Lower PT of $49.

Catalyst<ul> <li>Positive net inflow trends across all fund size buckets indicate growing institutional interest in RAL.</li></ul>Risk<ul> <li>Technical indicators show that the market is in a volatile state, and the direction is not clear enough.</li> <li>Market expectations tend to be pessimistic, with analyst ratings showing differences in consensus.</li></ul>

Key Factors

Ralliant reported a $1.4 billion non-cash goodwill impairment charge in its Test & Measurement segment amid a Q4 earnings report. Ralliant's shares plummeted 31.79% following the goodwill impairment charge and a 52-week low of $37.27. Ralliant faces a securities fraud investigation over its $1.4 billion goodwill impairment charge and subsequent share price decline. Ralliant set a 2026 revenue target of $2.1B-$2.2B amid strategic segment shifts and growth investments.

RAL News